- Report
- August 2023
- 51 Pages
Colombia
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Mexico
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Canada
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
United States
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Italy
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
China
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Netherlands
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Germany
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
France
From €529EUR$600USD£461GBP
- Report
- August 2023
- 51 Pages
Brazil
From €529EUR$600USD£461GBP
- Report
- December 2025
Global
From €600EUR$729USD£542GBP
- Report
- December 2025
Global
From €450EUR$547USD£406GBP
- Report
- December 2025
Global
From €450EUR$547USD£406GBP
- Report
- October 2025
- 82 Pages
Qatar
From €4276EUR$4,850USD£3,729GBP
- Report
- October 2025
- 87 Pages
South Korea
From €4276EUR$4,850USD£3,729GBP
- Report
- June 2025
- 80 Pages
From €3042EUR$3,450USD£2,653GBP
- Report
- December 2024
- 55 Pages
Global
From €2203EUR$2,499USD£1,921GBP
- Report
- October 2024
- 83 Pages
Global
From €4276EUR$4,850USD£3,729GBP
- Report
- September 2024
- 118 Pages
Global
From €3967EUR$4,500USD£3,460GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more